← Leaderboards
Mariana Murea
Wake Forest University Health Sciences
$3,022,787
Attributed
$5,813,074
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,813,074 · 2
By mechanism
R01$5,580,574 · 1
R03$232,500 · 1
Top collaborators
- Michael Allon5 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Jingzhong Ding$9,573,787
- Marco Pahor$75,096,124
- Osvaldo Delbono$18,067,544
- Candice D Fike$5,581,838
- Kylie Kavanagh$6,616,189
Others in their field
Other Emerging Leaders on “Measurement”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Yunda Huang · Fred Hutchinson Cancer Center$53,797,542
- Susan M Landau · University Of California Berkeley$47,252,026
- John Hobbs · Suny At Stony Brook$41,857,417
- Christopher Bee · Suny At Stony Brook$41,239,084
Research focus
MeasurementPhysical FunctionExhibitsHemodialysisOperative Surgical ProceduresPatient Outcomes AssessmentsDialysis ProcedureEnrollmentClinical TrialsHand StrengthOlder PatientAdultParticipantPatient-Focused OutcomesClient SatisfactionCathetersEligible ParticipantEnd Stage Renal FailureBlood VesselsAmericanFailureFistulaArteriovenous FistulaPilot Trial
Grant awards (7)
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$828,855
R01 · FY2025 · AG · contact PI
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,016,814
R01 · FY2024 · AG · contact PI
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,191,406
R01 · FY2023 · AG · contact PI
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,253,177
R01 · FY2022 · AG · contact PI
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,290,322
R01 · FY2021 · AG · contact PI
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease$116,250
R03 · FY2019 · AG · contact PI
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease$116,250
R03 · FY2018 · AG · contact PI